Blocknomi
Key Takeaways Jefferies shifted Zealand Pharma rating from Buy to Hold, pointing to absence of immediate catalysts Analysts reduced price target from DKK505 to DKK320 — representing a 37% decrease…
Related articles
-
Trump Won't Sign Housing Bill With CBDC Ban—Will It Become Law Tonight Anyway?
Decrypt Published 10.07.2026 15:13
-
Ethereum (ETH) Rises 8% Weekly: Is a Bigger Pump Coming Next?
CryptoPotato Published 09.07.2026 11:56
-
Bitcoin (BTC) Surges Past $61K Following Disappointing Jobs Report
Blocknomi Published 03.07.2026 07:02
-
Intel (INTC) Stock: Q1 Growth Sparks Questions About Long-Term Recovery Potential
Blocknomi Published 12.07.2026 15:11
-
Memecore’s M Rally: Is New Meme Beta Replacing the Old Dog-Coin Trade?
Crypto Daily Published 04.07.2026 09:01
-
Kraken Seeks Final Judgment After $22 Million Award Against Former Auditor
Bitcoin Magazine Published 07.07.2026 19:35
-
Revolut Links Crypto Exchange With AI Assistants
Blocknomi Published 10.07.2026 11:19
-
Bitmine Buys Another 42K ETH as 5% Supply Goal Comes Within Reach
CryptoPotato Published 06.07.2026 13:18